The forkhead box transcription factor FoxP3 controls the development and function of CD4 þ CD25 þ regulatory T (Treg) cell. FoxP3 modulates gene expression in Treg cells by multiple epigenetic mechanisms that are not clearly defined. We identified FoxP3-interacting proteins in human T cells by co-immunoprecipitation/MS. We discovered that FoxP3 interacted with linker histone H1.5 via the leucine zipper (LZ) domain. Two independent IPEX patient-derived single residue mutations in the LZ of FoxP3 both abrogated its interaction with H1.5. Functionally, FoxP3 and H1.5 cooperatively repressed interleukin-2 (IL-2) expression in human T cells; and silencing of H1.5 expression inhibited the ability of FoxP3 to suppress IL-2 expression. We show that FoxP3 specifically enhanced H1.5 association at the IL-2 promoter, but reduce its association at the CTLA4 promoter, correlated with higher or lower histone acetylation of the respective promoters. Finally, silencing of H1.5 expression in human Treg cells impaired the Treg function to suppress target T cells. We conclude that FoxP3 interacts with H1.5 to alter its binding to target genes to modulate their expression and to program Treg function.
Introduction
Regulatory T (Treg) cells are required for the maintenance of self-tolerance. The forkhead box transcription factor FoxP3 has been shown to be necessary for the Treg cell function. Scurfy mice deficient in FoxP3 function do not have CD4 þ CD25 þ regulatory T cells and develop severe autoimmune lymphoproliferative disease. 1, 2 Mutations in the foxp3 gene in humans also lead to immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, characterized by multiorgan T-cell infiltration and aggressive autoimmunity. 3, 4 Furthermore, ectopic expression of FoxP3 confers a suppressive phenotype to CD4 þ CD25 À T cells, characterized by decreased cytokine (interleukin-2 (IL-2), IL-4 and interferon-g) production and ability to suppress proliferation of other T cells. [5] [6] [7] FoxP3 is a member of the P subfamily of the forkhead (FKH) box transcription factors, which are characterized by a highly conserved winged-helix/FKH DNA-binding domain. 8 The FoxP3 protein includes an N-terminal proline-rich (PRR) domain, a C2H2 zinc finger, a leucine zipper (LZ), and a C-terminal FKH DNA-binding domain. The PRR domain of FoxP3 has been shown to be able to repress transcription by recruiting histone deacetylase-containing complexes. 9, 10 Mutations identified from IPEX patients within the FoxP3 gene show clusters of missense or in-frame deletion mutations within the leucine zipper and FKH domains, indicating the importance of these domains for FoxP3 function. 11 The leucine zipper region of FoxP3 is required for the function of FoxP3, as demonstrated by two independent mutations within the leucine zipper (D250K & D251E) derived from IPEX patients. 12 The FKH domain of FoxP3 has been shown to bind DNA and mediate repression of the IL-2 promoter in Treg cells. 13 Although IL-2 is important for Treg-cell development and survival, Treg cells themselves do not produce IL-2 in response to TCR stimulation. 14, 15 The repression of IL-2 in Treg cells has been linked directly to FoxP3 through several different mechanisms. FoxP3 has been proposed to bind NFAT and displace AP-1 binding, thereby inhibiting the transactivation of IL-2 by NFAT/AP1. 13 Furthermore, FoxP3 is also shown to interact with the transcription factor AML1/Runx1 to lead to IL-2 repression and Treg suppressive function. 16 Additionally, FoxP3 interactions with chromatin remodeling complexes containing histone deacetylases have been implicated in IL-2 repression and Treg function. 9 Linker histone H1 proteins have long been known to have an important role in the assembly of heterochromatin filaments associated with gene silencing. In mice and humans, five highly homologous linker histone isoforms (H1a to H1e or H1.1 to H1.5) have been identified, which are differentially regulated during development. 17 Although histone H1 depletion alters global chromatin structure, it surprisingly affects expression of only a few specific genes. 18 Mice with mutations in individual histone H1a, H1c, H1d, and H1e genes have been generated, with only subtle phenotypes. 19 Mice with triple mutations in H1c, H1d, and H1e genes are embryonic lethal and also show defects in expression and DNA methylation of only a few specific genes. 20 Thus, specific histone H1 isoforms may function in coordination with tissue-specific transcription factors to regulate specific genes during development and differentiation. Indeed, murine histone H1b is involved in cooperation with the muscle-specific transcription repressor Msx1 to repress MyoD expression and muscle differentiation. 21 We report here that the human linker histone H1.5 specifically binded FoxP3. The physical association of H1.5 with FoxP3 required the leucine zipper domain of FoxP3. Two independent IPEX patient-derived FoxP3 mutants of single residues in the LZ of FoxP3 also abrogated its interaction with H1.5. We show that ectopic expression of FoxP3 and H1.5 synergistically repressed expression of IL-2 in human T cells, associated with chromatin modifications. Conversely, silencing of H1.5 expression in human T cells abrogated the ability of FoxP3 to repress IL-2 expression. FoxP3 interacted with H1.5 to specifically enhance its association at the IL-2 promoter, but reduce its association at the CTLA4 promoter, correlated with higher or lower acetylation of the respective promoters. Finally, silencing of H1.5 expression in human Treg cells impaired the Treg function to suppress target T cells. These findings suggest that interaction of linker histone H1.5 with FoxP3 has an important role in FoxP3-mediated gene expression and in maintaining Treg cell functions by FoxP3.
Results
FoxP3 interacts specifically with linker histone H1. 5 To investigate the molecular mechanisms by which FoxP3 functions in regulatory T cells, and to identify proteins that bind FoxP3, we expressed FoxP3 in a human CD4 þ T cell line (Jurkat) with a retroviral vector. As expected, expression of FoxP3 in Jurkat cells inhibited IL-2 expression from the IL2 promoter following activation (Supplementary Figure S1) . To search for FoxP3-interacting proteins in these cell, we performed immunoprecipitation with an antibody specific for FoxP3. 22 Clarified lysates from Jurkat cells were immunoprecipitated with an anti-FoxP3 antibody and resolved on an sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel. Pre-blocking of the FoxP3 antibody with the specific FoxP3 peptide was used to identify specific FoxP3-interacting proteins that were pulled down by the immunoprecipitated FoxP3 protein (Figure 1a ). Mass spectrometry revealed that one major FoxP3-associated protein was human linker histone H1.5, with a protein To delineate the domain of FoxP3 required for binding to H1.5, we performed co-immunoprecipitation of H1.5 with truncated mutants of FoxP3 (Figure 2a ). The N-terminus domains including PRR and the zinc-finger regions of FoxP3 were dispensable for binding to H1.5, as the DN and DN-ZF FoxP3 proteins were able to interact with H1.5 ( Figure 2b) . The FoxP3 C-terminus region containing the forkhead DNA-binding domain (Fkh) was not sufficient for the interaction with H1.5, suggesting that the leucine zipper of FoxP3 is critical for the interaction. Importantly, two independent IPEX patients-derived mutations of a single amino-acid deletion within the leucine-zipper region of FoxP3 (del-251E or del-250K) abrogated FoxP3 binding to histone H1.5 ( Figure 2c ). However, IPEX mutations in the FKH domain that abrogate FoxP3 binding to DNA did not alter the ability of FoxP3 to bind to H1.5 (data not shown). Therefore, the interaction between FoxP3 and H1.5 does not require DNA binding by FoxP3, but requires critical residues in the LZ domain that are correlated with the biological activity of FoxP3. (Figure 3b ). When the chromatin structure at the IL-2 locus was analyzed, we confirmed that histone acetylation was partially reduced by FoxP3 expression, but completely repressed by FoxP3/H1.5 co-expression. In addition, the relative trimethylation of H3 at K4, K9 and K27 positions was also differentially modulated by FoxP3 and H1.5 ( Figure 3c ). Thus FoxP3 and H1.5 interact to cooperatively suppress IL-2 gene expression via epigenetic mechanisms in human T cells.
To genetically prove the role of H1.5 in FoxP3-mediated suppression of IL-2 gene expression, we silenced expression of endogenous H1.5 gene and tested its effect on FoxP3's ability to repress IL-2 expression in T (Figure 5b) . 31 When the FoxP3-enhanced CTLA4 gene was analyzed, FoxP3 significantly reduced the H1.5 association at the CTLA4 promoter (Figure 5c ), consistent with its enhanced expression and elevated histone acetylation level (Figure 5d ). In sum, our data support a model that FoxP3 modulates gene expression in T cells by modulating H1.5 binding at distinct target promoters.
H1.5, similar to FoxP3, is required for the suppression activity of Treg cells The human CD4 þ T cell subset (CD4 þ CD45RA þ CD25 þ ) with Treg cell potential (TNreg) has been recently reported to become fully functional Treg cells after activation and expansion, with further induction of FoxP3 expression and suppression activity. 23 To demonstrate that H1.5 is critical in the FoxP3-induced maturation of Treg cells with suppression activity, we investigated the effect of silencing endogenous H1. When expression of H1.5 was silenced in Treg cells, the suppression activity of Treg cells was also similarly reduced. Therefore, H1.5 is required for the FoxP3-induced suppression activity in Treg cells.
Discussion
In this study we demonstrate a novel mechanism by which FoxP3 modulates gene expression in regulatory T cells. FoxP3 specifically interacted with the linker histone H1.5. Co-expression of H1.5 and FoxP3 lead to synergistic repression of IL-2 expression in human T cells. Conversely, knockdown of H1.5 expression in human T cells inhibited the ability of FoxP3 to repress IL-2 expression. In addition, FoxP3 interacted with H1.5 to specifically enhance its association at the IL-2 promoter, but reduce its association at the CTLA4 promoter, correlated with higher or lower histone acetylation of the respective promoters. Finally, knockdown of either FoxP3 or H1.5 expression in human TNreg cells inhibited the ability of Treg cells to suppress target T cells, indicating that the interaction between FoxP3 and linker histone H1.5 is important for FoxP3 function in human regulatory T cells.
The FoxP3-H1.5 interaction required the leucinezipper domain of FoxP3, suggesting that dimerization of FoxP3 with itself or other proteins may be necessary for H1.5 binding. Importantly, the human IPEX mutations with the 251E or the 250K amino-acid deletion in the LZ region also both impaired its binding to H1.5, suggesting that H1.5 binding by FoxP3 has an important role in FoxP3 function. It has been reported that region of FoxP3 between the leucine zipper and forkhead domain (AA278-336) is critical for binding to the transcription factor RUNX/AML1. 16 It is possible that interaction with RUNX/AML1 may affect FoxP3 binding with H1.5, but it is not clear whether the 251E or the 250K FoxP3 mutant is still able to bind RUNX/AML1. Although previous studies have shown that the FoxP2/3 forkhead domain binds DNA and interacts with NFAT, 13 our studies demonstrated that the FoxP3 DNA-binding activity is not required for the physical interaction with H1.5, as shown with the IPEX mutations within the forkhead region of FoxP3 (Supplementary Figure S2) . However, it is clear that this FoxP3-H1.5 interaction is critical for IL-2 repression by FoxP3, and likely may modulate the expression of a group of target genes that are modulated by FoxP3 in regulatory T cells. 24 It will be of interest to identify genes/loci, the association of which with H1.5 is modulated by FoxP3 in T cells.
We propose that FoxP3 binds to the IL-2 promoter and recruits H1.5, leading to its repression. Two independent IPEX patients-derived FoxP3 mutants with a single deletion in the LZ domain also failed to recruit H1.5 to the IL2 promoter, suggesting that the binding of FoxP3 with H1.5 may have a critical role in the FoxP3 activity to reprogram Treg cells. Interestingly, the muscle-specific transcription repressor Msx1 also specifically interacts with murine H1b (homolog of human H1.5) to regulate mouse muscle cell differentiation. Msx1 binds and recruits H1b to the MyoD gene to repress its expression and muscle differentiation. 21 For target genes, the expression of which is enhanced by FoxP3 in Treg cells, FoxP3 reduced H1.5 binding to the CTLA4 promoter in activated T cells, via unclear mechanisms (Figure 5c ). Therefore, linker histone H1.5 has a special role in modulating gene transcription in T cells through association with transcription factors such as FoxP3. However, the H1.5 association at the CD25 promoter was not Although expression of H1.5/H1b decreases during differentiation in most tissues, H1.5/H1b expression is maintained at high levels in lymphocytes and lymphoid organs such as thymus and spleen. 25 It is likely that H1b is preferentially involved in lymphocyte differentiation and functions. To date, however, the H1b gene has not been knocked out in mice, which may prove to have a specific phenotype due to its expression and interactions with tissue-specific transcription factors. On the other hand, mice with mutations in one or two of the linker H1 histone genes have developed normally, with no significant differences in the total H1-to-nucleosome core H2-4 histone stoichiometry, indicating that H1 subtypes are able to compensate for each other during mouse development. 18, 19 It may be necessary to generate conditional mutant mice with inducible deletion of H1b gene in order to observe its effect in specific tissues or cell types. FoxP3 has been recently described to be associated with a chromatin remodeling complex including TIP60, HDAC7 and members of the SWI/SNF family. 9, 26 We describe here another mechanism of FoxP3 transcriptional modulation through modulation of linker histone H1.5 binding to alter the chromatin structure at FoxP3-responsive genes. Our results do not preclude the idea that FoxP3 may form a large complex with H1.5, other transcription factors and chromatin remodeling complexes. Indeed, another human histone H1 isoform, H1.4, has recently been reported to specifically interact with the malignant brain tumor protein L3MBTL1 to compact chromatin and repress expression of E2F-regulated genes.
27
FoxP3 may similarly alter the chromatin structures at distinct gene loci to coordinate Treg maturation and functions. Additionally, the reciprocal binding of PARP-1 and Histone H1 has been shown to effect gene expression outcomes. 28 Thus, it is likely that the combination of these factors is required for 
Materials and methods
Plasmids, antibodies and cell lines FoxP3 was expressed from the HSPG retrovirus vector. 29 Deletion mutants of FoxP3 were generated by PCR amplification to specifically remove the N-terminus (aa 1-189), the N-terminus with the Zinc-finger motif (aa 1-241), the N-terminus including the zinc finger and the leucine zipper (aa 1-337). Human H1.5 was PCR amplified from genomic Jurkat cell DNA and cloned into the pHITflag vector. pcDNA-V5-H1a and pcDNA-HAH1d were generous gifts from Dr Corey Abate-Shen. 21 The D251E and D250K point mutants were introduced into FoxP3 by site-directed mutagenesis and verified by DNA sequencing. The NS shRNA plasmid (pLL5.0NS) was a kind gift from Dr Jim Bear. 30 The nonspecific shRNA was generated by using the target loop sequence 5 0 -GATCGACTTACGACGTTAT-3 0 . The H1.5 shRNA was purchased from Open Biosystems (Huntsville, AL, USA) in the pGINZeo vector, using the H1.5 target loop sequence 5 0 -TAGTGAAGCCACAGATGTA-3 0 . Jurkat cells were maintained in RPMI 1640 (Gibco BRL, Carlsbad, CA, USA), 293T cells were maintained in DMEM and human primary T cells were maintained in Iscoves MEM, supplemented with 10% fetal bovine serum (Sigma, St Louis, MO, USA), 2 mM L-glutamine, 100 U ml À1 penicillin, 100 U ml À1 streptomycin. For T-cell activation, PMA (Sigma, 25 ng ml
À1
) and ionomycin (Sigma, 1 mM), mouse anti-CD3 mouse, anti-CD28 (BD Biosciences, San Jose, CA, USA) and goat anti-mouse IgG (Caltag, Carlsbad, CA, USA) were used. FoxP3 antibodies have been previously described. 22 The peptide from the N-terminus of murine FoxP3 (C-LLGTRGS GGPFQGRDLRSGAH) was used to immunize rabbits for production of polyclonal antibodies. Affinity purification of the antibodies was performed with a SulfoLink Kit (Pierce Biotechology, Rockford, IL, USA). The mouse anti-myc (9E10) monoclonal supernatant was kindly provided by Dr Y Xiong (UNC, NC). The mouse antiFlag M2 (Sigma) and the rabbit anti-histone H1.5 from Abcam (Cambridge, MA, USA) were used.
Retrovirus and lentiviral vector production and transduction 293T cells were co-transfected with retroviral vector, VSV-g and Gag-Pol containing plasmids by calcium phosphate, as previously described. 29 For retroviral transduction, Jurkat cells were spinoculated with retrovirus to 490% efficiency as measured by GFP expression. 31 For VSV-g pseudotyped HIV-derived lentiviral vector production, 293T cells were transfected with Effectene (Qiagen, Valencia, CA, USA) transfection reagent per manufacturer's instructions. At 48 h post transfection, supernatants were used to infect Jurkat cells by spinoculation.
Immunoprecipitations
Whole-cell extracts were made from FoxP3-transduced Jurkat cells using modified RIPA extraction buffer. Extracts (40 mg) were immunoprecipitated using affinity-purified anti-FoxP3 (Li195) antibodies in phosphatebuffered saline, 10 mM NaVO 4, 10 mM DTT, 1 mM PMSF and 1X protease inhibitor cocktail (Roche, Indianapolis, IN, USA). FoxP3 antibodies were pre-incubated for 1 h with the Li195 peptide, before immunoprecipitation for the peptide specificity control. Immune complexes were precipitated by addition of Protein A agarose beads (Pierce, Rockford, IL, USA). Complexes were eluted by boiling in sodium dodecyl sulfate-loading dye buffer, resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and visualized with Coomassie Brilliant Blue stain. Protein bands were cut from the gel and sequence analysis was carried out by the UNC Proteomics Core Facility by reverse-phase HPLC tandem mass spectrometry (LC/MS). Co-immunoprecipitation experiments were carried out using nuclear extracts of 293T cells transfected (Effectene, Qiagen) with flag-tagged H1b and myc-tagged-FoxP3, using either mouse antimyc (9E10) hybridoma supernantant or mouse anti-flag M2 (Sigma) antibodies. Proteins were analyzed by immunoblotting and detection with ECL plus western blotting detection (Amersham, Piscataway, NJ, USA).
Chromatin immunoprecipitation assays (ChIPs)
Jurkat T cells were retrovirally transduced with control or flag-H1b expressing virus, followed by a second transduction 48 h later with control or FoxP3 expressing virus. Sonicated chromatin from the Jurkat cells was immunoprecipitated with control IgG (IgG) or anti-myc (9E10) (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) or anti-flagM2 (Sigma) by chromatin immunoprecipitation assay kit per the manufacturer's instruction (Upstate, Lake Placid, NY, USA, Millipore, Billerica, MA, USA), as previously reported. 31 Samples were purified and subject to real-time qPCR analysis. IL-2 promoter was analyzed with Sybergreen reagents using the following primers: 5 0 -CACCTAAGTGTGTGGGCTAATGTAAC-3 0 and 5 0 -CT GATGACTCTTTGGAATTTCTTTAAACC-3
0 . This amplicon spans À226 to À133 in the human IL-2 promoter and spans the NFkB and AP-1 sites. The relative mycFP3 or flagH1b binding of IL-2 promoter is expressed with ratios of ChIP-specific signal divided by signals from control 10% input chromatins, thereafter normalized to non-specific IgG antibody binding.
Primary human T-cell purification and transfection CD4 þ primary T cells were purified from Ficollseparated peripheral blood mononuclear cell by MACS human CD4 þ T-cell isolation kit (490% purity, Miltenyi-Biotech, Auburn, CA, USA). Purified primary CD4 þ T cells were transfected by using the Amaxa nucleofector kit (Amaxa Biosystems, Gaithersburg, MD, USA). Briefly, 10 Â 10 6 unstimulated CD4 þ T cells were transfected with 2 mg of plasmid DNA (B50% efficiency by GFP expression), and cultured for 24 h before activation.
IL-2 ELISA
Jurkat T cells were activated by PMA (25 ng ml À1 ) and ionomycin (1 mM) for 16 h. Media supernatants were harvested and analyzed by the human IL-2 ELISA kit (BD Biosciences), as per manufacturer's instructions. Primary CD4 þ T cells were activated by anti-CD3/CD28 monoclonal antibody cross-linked by plate-bound antimouse IgG as previously described. Briefly, purified cells are stained with anti-CD3 (0.5 mg ml À1 ) and anti-CD28 (2 mg ml
À1
) and incubated on plated-bound goat antimouse IgG. Cells were activated for 72 h, and media supernatants were harvested for IL-2 ELISA. Four independent experiments (each in triplicates) are carried out.
Isolation, expansion and lentiviral transduction of TNreg cells Isolation, expansion and lentiviral transduction of TNreg cells were performed as recently reported. 23 Briefly, naive and TNreg cells were sorted from human blood as described before. 23 Cells were activated with monocytederived dendritic cells and SEB, and grown for 5 days before infected by shRNA-expressing virus supernatant. Preparation of the control and Foxp3 shRNA viruses has been described. 23 Cells were then expanded for another week, sorted based on GFP expression and GFP þ cells were used as effectors in a suppression assay.
Treg suppression assay Naive CD4 þ T cells were labeled with PKH26 (Invitrogen), and used as target cells. Target cells and different effector cells were mixed at a ratio 1:4 or 1:8, and stimulated with dendritic cell (1:30) and SEB (10B0.1 pg ml À1 ). Proliferation of the target cells were examined 4 or 5 days post stimulation. 23 
Statistical analysis
For statistical analysis, a two-tailed Student t-test is used where Po0.05 is considered significant.
